Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 2Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 14INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Breast Neoplasms 169Neoplasms 128Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 30Neoplasm Metastasis 27Skin Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Liver Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Multiple Sclerosis × Clear all
NCT06136923 2024-05-13

An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer

Click Therapeutics, Inc.

Phase NA Completed
194 enrolled
BreastThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Sclerosis

NCT05438147 2023-04-26

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Click Therapeutics, Inc.

Phase NA Completed
114 enrolled

Multiple Sclerosis, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡